Buy Fulcrum Therapeutics Inc Stock | FULC Stock Price & Latest News | Public
FULC

Fulcrum Therapeutics Inc

$0.00 (0.00%)Today

    About FULC

    Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.27
    -0.54
    -0.81
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.72

    Actual EPS
    Q4 2020

    Stats

    Market Cap$298,79M
    Volume3,65k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$22.96
    1 Year Low$7.01
    Open$10.54
    High$10.76
    Low$10.48

    Buy any stock with any amount of money.

    Download the App
    Download the app